Summary

Article Metadata

Breakthrough Prize for Ozempic-Style Drugs

This is a Glucagon news story, published by Live Science.

Glucagon news

For more Glucagon news, you can click here:

more Glucagon news

physics news

For more physics news, you can click here:

more physics news

Live Science news

For more news from Live Science, you can click here:

more news from Live Science

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like physics news, you might also like this article about

life sciences awards

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Breakthrough Prize news, Breakthrough Prizes news, physics news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

insulin secretion

Live Science

Live Science

•

Science

Science

$3 million prize goes to developers of Ozempic-style drugs

Live Science

Summary

Nutrition label

75% Informative

Five scientists who helped develop Ozempic-style drugs have been awarded a $3 million prize nicknamed the "Oscars of Science " The Breakthrough Prizes are annual awards that aim to recognize "the world’s top scientists working in the fundamental sciences" Glucagon -like peptide 1 , or GLP-1 , is a hormone that the gut secretes after eating.

These drugs have garnered significant popularity over the past decade .

VR Score

84

Informative language

89

Neutral language

26

Article tone

informal

Language

English

Language complexity

63

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

17

https://hsph.harvard.edu/profile/alberto-ascherio/https://lmp.utoronto.ca/faculty/daniel-drucker https://breakthroughprize.org/About https://researchers.mgh.harvard.edu/profile/3589750/Joel-Habener https://www.rockefeller.edu/our-scientists/research-affiliates/1055-svetlana-mojsov/https://www.kff.org/health-costs/poll-finding/kff-health-tracking-poll-may-2024-the-publics-use-and-views-of-glp-1-drugs/https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14313 https://www.ahajournals.org/doi/10.1161/atvbaha.106.131755 https://www.harringtondiscovery.org/scholars/jens-j-holst https://pmc.ncbi.nlm.nih.gov/articles/PMC11781064/https://www.cancer.org/cancer/risk-prevention/diet-physical-activity/body-weight-and-cancer-risk.html https://journals.physiology.org/doi/full/10.1152/physrev.00034.2006?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org https://profiles.ucsf.edu/stephen.hauser https://www.wegovy.com/https://www.ozempic.com/https://scholar.google.com/citations?user=s-0BmrMAAAAJ&hl=en https://www.chemistry.harvard.edu/people/david-r-liu

Source diversity

17

hsph.harvard.edu lmp.utoronto.ca breakthroughprize.org researchers.mgh.harvard.edu www.rockefeller.edu www.kff.org alz-journals.onlinelibrary.wiley.com www.ahajournals.org www.harringtondiscovery.org pmc.ncbi.nlm.nih.gov www.cancer.org journals.physiology.org profiles.ucsf.edu www.wegovy.com www.ozempic.com scholar.google.com www.chemistry.harvard.edu

Affiliate links

3

https://go.redirectingat.com/?id=92X1590019&xcust=livescience_us_3414239076621814886&xs=1&url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41573-020-0084-6&sref=https%3A%2F%2Fwww.livescience.com%2Fhealth%2Fobesity%2F3-million-breakthrough-prize-awarded-to-developers-of-ozempic-style-drugs https://go.redirectingat.com/?id=92X1590019&xcust=livescience_us_1101522579728939716&xs=1&url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41430-024-01460-6&sref=https%3A%2F%2Fwww.livescience.com%2Fhealth%2Fobesity%2F3-million-breakthrough-prize-awarded-to-developers-of-ozempic-style-drugs https://go.redirectingat.com/?id=92X1590019&xcust=livescience_us_3480172935310500958&xs=1&url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41576-022-00541-1&sref=https%3A%2F%2Fwww.livescience.com%2Fhealth%2Fobesity%2F3-million-breakthrough-prize-awarded-to-developers-of-ozempic-style-drugs

Read full article